Cargando…
Continuous 5-fluorouracil in the treatment of breast cancer.
Prolonged infusions of 5-fluorouracil (5-FU) have been used since the early 1960s, but recently there has been a major resurgence of interest, partly because of the advent of electronically controlled portable infusion pumps. This paper looks at the published data on continuously infused 5-FU in bre...
Autores principales: | Cameron, D. A., Gabra, H., Leonard, R. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033324/ https://www.ncbi.nlm.nih.gov/pubmed/8018521 |
Ejemplares similares
-
Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.
por: Gabra, H., et al.
Publicado: (1996) -
5-fluorouracil-induced leukoencephalopathy in patients with breast cancer.
por: Choi, S. M., et al.
Publicado: (2001) -
A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.
por: Ando, M., et al.
Publicado: (1998) -
Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989) -
Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2(+) Breast Cancer Cells to 5-Fluorouracil
por: Yi, Jianing, et al.
Publicado: (2020)